
Neil D'Souza
MD
Radiation Oncologist
Languages spoken
English, Spanish
Overview
Neil D'Souza, MD is a board-certified radiation oncologist with expertise in all modern radiation modalities and a broad range of cancer types, including breast, prostate, head and neck, gastrointestinal, thoracic, brain, skin, and metastatic disease. He is also among the nation's most experienced practitioners of Low-Dose Radiation Therapy (LDRT), an emerging and highly effective treatment for osteoarthritis and other painful musculoskeletal conditions. He is committed to providing integrative, patient-centered care by combining advanced radiation therapy with evidence-based lifestyle optimization, communicated with clarity and compassion.
Dr. D'Souza earned his undergraduate degree from Rice University and his medical degree from Baylor College of Medicine as part of the competitive Rice-Baylor BA/MD program. He completed his internship and residency at UT Health San Antonio–MD Anderson Mays Cancer Center, where he served as Chief Resident and trained at one of the country's highest-volume cancer centers. Prior to joining GenesisCare, he led the development of a new radiation oncology service line in Arizona, which included launching the state's first LDRT program.
Dr. D'Souza has been actively involved in clinical research and has co-authored several peer-reviewed publications. He remains committed to innovation and excellence in cancer care through ongoing learning and collaboration.
- Radiation Oncologist, GenesisCare
- Radiation Oncologist, Arizona Oncology Associates
- M.D., Baylor College of Medicine, Houston, Texas
- B.A., Rice University, Houston, Texas
- Internal Medicine, University of Texas Health Science Center - San Antonio, San Antonio, Texas
- Radiation Oncology, UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas
- Rice University/Baylor College of Medicine Medical Scholar 2010 - 2017
- Rice University Trustee Distinguished Scholar 2013
- Rice University Century Research Scholar 2013
- Siemens Competition National Semifinalist 2010
- National Merit Scholarship Winner 2010
- D'Souza NM, Fang P, Logan J, Yang J, Jiang W, Li J. Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies. Front Oncol. 2016;6:212
- Mesko S, Deegan BJ, D'Souza NM, Ghia AJ, Chapman BV, Amini B, McAleer MF, Wang XA, Brown PD, Tatsui CE, Rhines L, Li J. Spine Stereotactic Radiosurgery for Metastatic Pheochromocytoma. Cureus 11(5): e4742. doi:10.7759/cureus.4742
- An Y, Jiang W, Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D’Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja BS. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides. Radiother Oncol. 2019;131:88-92.
- D'Souza NM, Nguyen HD, Smith SV, et al. Metastatic Melanoma of the Optic Nerve Sheath. Neuroophthalmology. 2018;42(3):187-190
- An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, Lin SH, Yu JB, Davies MA, Hwu P, Sulman EP, Brown PD, Chiang VLS, Li J. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. Radiother Oncol. 2017;125(1):80-88.;
- Glitza IC, Guha-thakurta N, D'Souza NM, et al. Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases. Melanoma Res. 2017;27(6):580-584.
- D'Souza NM, Morgan ML, Almarzouqi SJ, Lee AG. Magnetic resonance imaging findings in giant cell arteritis. Eye (Lond). 2016;30(5):758-62.